Advertisement
Advertisement
BLCO
Bausch + Lomb Corporation
16.18
USDSponsored
+0.27
+1.70%
May 08, 15:59 UTC -4
Closed
After-Market
16.11
-0.07
-0.46%
BLCO Earnings Reports
Positive Surprise Ratio
BLCO beat 12 of 16 last estimates.
75%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Bausch + Lomb Corporation earnings per share and revenue
On Apr 29, 2026, BLCO reported earnings of 0.08 USD per share (EPS) for Q1 26, beating the estimate of 0.05 USD, resulting in a 36.52% surprise. Revenue reached 1.24 billion, compared to an expected 1.24 billion, with a 0.13% difference. The market reacted with a -2.42% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
Concentra Group Holdings Parent, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.34
Actual
$0.40
Surprise
+17.03%
CVS HEALTH CORPORATION
Report Date
May 06, 2026 For Q1 26
Estimate
$2.21
Actual
$2.57
Surprise
+15.80%
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
agilon health, inc.
Report Date
May 06, 2026 For Q1 26
Estimate
$0.91
Actual
$1.80
Surprise
+97.04%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
FAQ
What were Bausch + Lomb Corporation's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Bausch + Lomb Corporation reported EPS of $0.08, beating estimates by 36.52%, and revenue of $1.24B, 0.13% above expectations.
How did the market react to Bausch + Lomb Corporation's Q1 2026 earnings?
The stock price moved down -2.42%, changed from $15.72 before the earnings release to $15.34 the day after.
When is Bausch + Lomb Corporation expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Bausch + Lomb Corporation's next earnings report?
Based on --
analysts, Bausch + Lomb Corporation is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement